Proposed criteria* | Dispenzieri,4
5
Kuwabara et al 6† | Dispenzieri et al 7‡ |
Major criteria | ||
1.Polyneuropathy (typically demyelinating)§ | 1.Polyneuropathy (typically demyelinating)§ | 1.Polyneuropathy§ |
2.Monoclonal plasma cell proliferative disorder§ | 2.Monoclonal plasma cell proliferative disorder§ | 2.Monoclonal plasmaproliferative disorder§ |
3.Vascular endothelial growth factor elevation§ | 3.Castleman disease¶ | |
4.Sclerotic bone lesions | ||
5.Vascular endothelial growth factor elevation | ||
Minor criteria | ||
4.Extravascular volume overload | 6.Organomegaly | 3.Sclerotic bone lesions |
5.Skin changes | 7.Extravascular volume overload | 4.Castleman disease |
6.Organomegaly | 8.Endocrinopathy | 5.Organomegaly |
7.Sclerotic bone lesions | 9.Skin changes | 6.Oedema |
10.Papilloedema | 7.Endocrinopathy | |
11.Thrombocytosis/polycythaemia | 8.Skin changes | |
9.Papilloedema |
*All of the three major criteria and at least two of the four minor criteria are required for diagnosis.
†Both of the mandatory criteria, one of the three other major criteria and at least one of the six minor criteria are required for diagnosis.
‡Both of the mandatory criteria and at least one of the seven minor criteria are required for diagnosis.
§Mandatory criteria.
¶There is a Castleman disease variant of POEMS syndrome that occurs without evidence of a clonal plasma cell disorder that is not accounted for in this table. This entity should be considered separately.
POEMS, polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes.